Market report
Dermatological drug tenders in Czechia — market report, January 2025
Dermatological drug tenders in Czechia in January 2025: 4,714 tenders published (-28% month on month), estimated at €584,738 in total, and 4,725 contracts awarded (-28% month on month), worth €1,390,522 (awarded value). Buyers with the most tenders: Krajská zdravotní, a.s. (855), Krajská nemocnice T. Bati, a. s. (413) and Fakultní nemocnice Bulovka (407); most contracts won: ViaPharma s.r.o. (174), ROCHE s.r.o. (161) and Janssen-Cilag s.r.o. (109). On average 1.7 bids per contract; 69% of contracts had a single bid. Report made on 27 October 2026.
- Tenders published
- 4,714
- Contracts awarded
- 4,725
- Contract value awarded
- €1,390,522
- Bids per contract
- 1.7
The highlighted bar is January 2025. Hover a bar for its figure; the table below has every value.
| Figure | January 2025 | December 2024 | Change | Same month last year | Change |
|---|---|---|---|---|---|
| Tenders published | 4,714 | 6,565 | -28% | — | — |
| Estimated value | €584,738 | €386,903 | +51% | — | — |
| Buyers | 29 | 34 | -15% | — | — |
| Contracts awarded | 4,725 | 6,569 | -28% | — | — |
| Contract value (awarded) | €1,390,522 | €83,574 | +1,564% | — | — |
| Winners | 229 | 276 | -17% | — | — |
| Bids per contract | 1.7 | 1.6 | — | — | — |
| Single-bid contracts | 69% | 60% | — | — | — |
Buyers with the most tenders
Companies with the most contracts
| # | Winners | Contracts |
|---|---|---|
| 1 | ViaPharma s.r.o. | 174 |
| 2 | ROCHE s.r.o. | 161 |
| 3 | Janssen-Cilag s.r.o. | 109 |
| 4 | Amgen s.r.o. | 104 |
| 5 | AbbVie s.r.o. | 87 |
| 6 | Avenier a.s. | 77 |
| 7 | Takeda Pharmaceuticals Czech Republic s.r.o. | 70 |
| 8 | BAYER s.r.o. | 67 |
| 9 | Gilead Sciences s.r.o. | 47 |
| 10 | ELI LILLY ČR, s.r.o. | 44 |
Where the tenders were
Procedures
The report's aggregates: the figures, the comparisons and the top lists by name and count.
All reports: Dermatological and musculoskeletal drugs
Questions and answers
- How many dermatological drug tenders were published in Czechia in January 2025?
- 4,714 (by 29 buyers); for comparison, December 2024: 6,565.
- Who won the most dermatological drug tenders in Czechia in January 2025?
- By number of contracts: ViaPharma s.r.o. (174), ROCHE s.r.o. (161), Janssen-Cilag s.r.o. (109), Amgen s.r.o. (104) and AbbVie s.r.o. (87); 229 companies won contracts in all.
- Which buyers published the most dermatological drug tenders in January 2025?
- Krajská zdravotní, a.s. (855), Krajská nemocnice T. Bati, a. s. (413), Fakultní nemocnice Bulovka (407), Fakultní nemocnice Brno (377) and Nemocnice České Budějovice, a.s. (305).
- How competitive were dermatological drug tenders in Czechia in January 2025?
- On average 1.7 bids per contract (16 contracts with a known number of bids); 69% of contracts had a single bid.
- What were the contracts worth in January 2025?
- €1,390,522 (awarded value, 4,725 contracts); median about €4,300.
How the report is made
Tenders published: the tenders of the sector or topic whose first notice is dated in the month (a tender counts in its sector and in up to three topics). Contracts awarded: the awards dated in the month, whenever their tender was published. Values in EUR, by value kind (never added together); medians are approximate (±3 %). Comparisons: with the reports of the previous month and of the same month a year earlier, each made the same way. The report was made on 27 October 2026 from the data of that day and is not changed afterwards; sources publish late, so later data for the month are not in it.